Emerging Gene Therapies for Retinal Degenerations
نویسندگان
چکیده
منابع مشابه
Emerging gene therapies for retinal degenerations.
Introduction Our most cherished sense, vision, begins with the process of phototransduction, a process performed by the highly specialized photoreceptor cells of the retina: the rods and cones (Rodieck, 1998). Rod photoreceptor cells are needed for night vision, as they are able to respond to very few photons, while cones are active under bright light conditions and are responsible for color vi...
متن کاملRetinal Degenerations: Genetics, Mechanisms, and Therapies
The cumulative results from genetic research and treatment protocols tested on cell and animal models have improved our understanding of pathobiology of inherited and degen-erative eye diseases, and have lead to the development of a broad range of potential strategies to treat these conditions. In this special issue of the Journal of Ophthalmology, a series of articles provide a review of vario...
متن کاملClinical characteristics and current therapies for inherited retinal degenerations.
Inherited retinal degenerations (IRDs) encompass a large group of clinically and genetically heterogeneous diseases that affect approximately 1 in 3000 people (>2 million people worldwide) (Bessant DA, Ali RR, Bhattacharya SS. 2001. Molecular genetics and prospects for therapy of the inherited retinal dystrophies. Curr Opin Genet Dev 11: 307-316.). IRDs may be inherited as Mendelian traits or t...
متن کاملProspectives for Gene Therapy of Retinal Degenerations
Retinal degenerations encompass a large number of diseases in which the retina and associated retinal pigment epithelial (RPE) cells progressively degenerate leading to severe visual disorders or blindness. Retinal degenerations can be divided into two groups, a group in which the defect has been linked to a specific gene and a second group that has a complex etiology that includes environmenta...
متن کاملEmerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neuroscience
سال: 2012
ISSN: 0270-6474,1529-2401
DOI: 10.1523/jneurosci.0295-12.2012